tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SNYNF Stock Latest News

FDA moves to accelerate biosimilar development, lower drug costs
The FlyFDA moves to accelerate biosimilar development, lower drug costs
3d ago
AZN
BMY
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
PremiumCompany Announcements
Sanofi’s New Study on Balinatunfib: A Potential Game-Changer for IBD Treatment
4d ago
SNYNF
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
PremiumCompany Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications
6d ago
REGN
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
PremiumCompany Announcements
Regeneron and Sanofi’s Phase 3 COPD Study Completes: Market Implications Ahead
6d ago
REGN
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
PremiumCompany Announcements
Sanofi’s Phase 2 Cancer Study Update: Implications for Investors
6d ago
SNYNF
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
PremiumThe FlyAvidity Biosciences downgraded to Neutral from Buy at Roth Capital
6d ago
LLY
MRK
Sanofi assumed with a Buy at Jefferies
Premium
The Fly
Sanofi assumed with a Buy at Jefferies
6d ago
SNY
Morning Movers: Intel, Ford rise after earnings
Premium
The Fly
Morning Movers: Intel, Ford rise after earnings
9d ago
F
GD
Sanofi reports Q3 IRFS EPS EUR 2.30, up 2.2% reported
PremiumThe Fly
Sanofi reports Q3 IRFS EPS EUR 2.30, up 2.2% reported
9d ago
SNY
Sanofi expects FY25 business EPS growth at LDD percentage at CER
PremiumThe Fly
Sanofi expects FY25 business EPS growth at LDD percentage at CER
9d ago
SNY
ImageneBio initiated with an Outperform at Leerink
PremiumThe Fly
ImageneBio initiated with an Outperform at Leerink
9d ago
IMA
SNY
Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects
PremiumRatings
Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects
9d ago
SNY
Ventyx ‘unequivocally impressive data’ should spur Sanofi, says Clear Street
PremiumThe FlyVentyx ‘unequivocally impressive data’ should spur Sanofi, says Clear Street
10d ago
SNY
VTYX
Sanofi, Medidata expand partnership
Premium
The Fly
Sanofi, Medidata expand partnership
10d ago
SNY
Trump Trade: Trump administration prepares new probe into pharma prices
Premium
The Fly
Trump Trade: Trump administration prepares new probe into pharma prices
11d ago
CI
AZN
Trump admin prepares new probe into U.S. pharma prices, FT says
PremiumThe Fly
Trump admin prepares new probe into U.S. pharma prices, FT says
11d ago
CI
AZN
SNYNF Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SNYNF Earnings this Week: How Will it Perform?
11d ago
Sanofi announces Tzield sBLA accepted for expedited review by FDA
PremiumThe Fly
Sanofi announces Tzield sBLA accepted for expedited review by FDA
13d ago
SNY
Sanofi says CHMP issues negative opinion on MAA for Rezurock
PremiumThe Fly
Sanofi says CHMP issues negative opinion on MAA for Rezurock
16d ago
SNY
Sanofi says CHMP adopts positive opinion recommending Wayrilz approval
PremiumThe FlySanofi says CHMP adopts positive opinion recommending Wayrilz approval
16d ago
SNY
Sanofi’s Rilzabrutinib Trial: A Potential Game-Changer for IgG4-related Disease
Premium
Company Announcements
Sanofi’s Rilzabrutinib Trial: A Potential Game-Changer for IgG4-related Disease
17d ago
SNYNF
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
Premium
Company Announcements
Sanofi’s New COPD Treatment Study: A Potential Game-Changer?
19d ago
SNYNF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >